# Erythropoietin Role in Acute Kidney Injury

> **NCT03401710** · NA · TERMINATED · sponsor: **Saint-Joseph University** · enrollment: 134 (actual)

## Conditions studied

- Anemia Renal

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT03401710
- **Lead sponsor:** Saint-Joseph University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-16
- **Primary completion:** 2021-03-20
- **Final completion:** 2021-08-25
- **Target enrollment:** 134 (ACTUAL)
- **Why stopped:** For very slow recruitment
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03401710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03401710, "Erythropoietin Role in Acute Kidney Injury". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03401710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*